checkAd

     233  0 Kommentare Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference

    Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Credit Suisse Annual Health Care Conference on Wednesday, November 14, 2018 in Scottsdale, AZ. Chris Boerner, chief commercial officer, will answer questions about the company at 8 a.m. MT (10 a.m. ET).

    Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Bristol-Myers Squibb!
    Long
    40,05€
    Basispreis
    0,47
    Ask
    × 8,88
    Hebel
    Short
    50,43€
    Basispreis
    0,52
    Ask
    × 8,02
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    About Bristol-Myers Squibb

    Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitter, YouTube and Facebook.



    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Credit Suisse Annual Health Care Conference on Wednesday, November 14, 2018 in Scottsdale, AZ. Chris Boerner, chief commercial officer, will answer questions about …

    Schreibe Deinen Kommentar

    Disclaimer